Treace Medical Concepts TMCI
NASDAQ TMCI
$4.21 +0.07 (+1.69%)
As of: Oct 22, 2026 · 11:36 AM EDT

Treace Medical Concepts (TMCI) Short term Debt (2020)

Updated

Treace Medical Concepts (TMCI) recorded Short term Debt of $1.79 million in Q4 2020.

Analysis

Treace Medical Concepts (TMCI) Short term Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 253.91 Bn 232.94 Bn 4.88 Bn
2 Abbott Laboratories 177.14 Bn 147.57 Bn 7.27 Bn
3 Danaher 164.94 Bn 148.75 Bn 3.61 Bn
4 Intuitive Surgical 155.60 Bn 135.02 Bn 1.96 Bn
5 Medtronic 122.76 Bn 88.01 Bn 6.34 Bn
6 Stryker 118.18 Bn 104.29 Bn 4.50 Bn
7 Boston Scientific 66.96 Bn 61.72 Bn 3.85 Bn
8 Becton Dickinson 54.55 Bn 51.70 Bn 2.32 Bn
9 Edwards Lifesciences 51.58 Bn 35.58 Bn 1.35 Bn
10 Treace Medical Concepts 273.86 Mn 70.60 Mn 35.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 1.79 Mn
API Access

Treace Medical Concepts Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TMCI&period=max&api_key=YOUR_API_KEY